Tuesday, October 04, 2022 7:43:01 PM
But we have seen that news releases from Koos either in the form of a PR or SEC filing no longer have that miracle run excitement as we saw early in 2021 when the uninitiated have no idea what they were investing in. Now that many know of the stink that Regen and Koos both hold, no one is really excited about RGBP anymore, especially when they see Oncofakeapharma take a hard pass on Koos' IP, see that Dyo Bio is a non existent company, and realize that Koos is a "none" trick pony who promises a lot but never comes through, like say with a CSO or white paper and pays his brother $117K to do absolutely NOTHING.
Astute investors can smell a fraud and why no astute investor is investing in RGBP.
FACTS are stubborn things
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM